- Share this article on Facebook
- Share this article on Twitter
- Share this article on Email
- Show additional share options
- Share this article on Print
- Share this article on Comment
- Share this article on Whatsapp
- Share this article on Linkedin
- Share this article on Reddit
- Share this article on Pinit
- Share this article on Tumblr
Sony’s cinematic universe based on Spider-Man characters just got a little bigger.
The studio is developing Morbius, a feature project centered on Spider-Man antihero Morbius the Living Vampire.
Burk Sharpless and Matt Sazama, who worked on the recent Power Rangers movie, wrote the script, which was just submitted to the studio after a secret development process.
Morbius was created by writer Roy Thomas and artist Gil Kane and first appeared in Amazing Spider-Man #101, the first issue not written by Spider-Man co-creator Stan Lee.
Morbius is Dr. Michael Morbius, a scientist who suffered from a rare blood disease and attempted to cure himself to disastrous results. He instead became afflicted with a condition that was a form of vampirism — the thirst for blood, along with fangs and super strength — and fought Spider-Man. Over time, however, he became a slightly heroic figure in his own right.
Details of Sony’s take on the character are not known.
Sony has been furiously developing its stable of Marvel-licensed characters that are mostly based off the heroes and villains that are connected to Spider-Man. The studio, however, is being coy as to whether or not these new movies will be connected to Sony’s Tom Holland movies or connected to the Marvel Cinematic Universe that is being produced by Marvel Studios.
Sony had no comment.
Sharpless and Sazama previously tackled vampirism with Dracula Untold, Universal’s origin of the most famous vampire that starred Luke Evans. They also count The Last Witch Hunter and Gods of Egypt among their credits.
The duo also are showrunning and writing the Lost in Space reboot for Netflix that is to debut next year.
They are repped by ICM Partners.
Sign up for THR news straight to your inbox every day